Repository landing page

We are not able to resolve this OAI Identifier to the repository landing page. If you are the repository manager for this record, please head to the Dashboard and adjust the settings.
oaioai:doaj.org/article:ad3ca81d39e04ec3bde098d094848ef3

The serotonergic system and cognitive function

Authors
Publication date
1 January 2016
Publisher
'Walter de Gruyter GmbH'
Doi

    Abstract

    Symptoms of cognitive dysfunction like memory loss, poor concentration, impaired learning and executive functions are characteristic features of both schizophrenia and Alzheimer’s disease (AD). The neurobiological mechanisms underlying cognition in healthy subjects and neuropsychiatric patients are not completely understood. Studies have focused on serotonin (5-hydroxytryptamine, 5-HT) as one of the possible cognitionrelated biomarkers. The aim of this review is to provide a summary of the current literature on the role of the serotonergic (5-HTergic) system in cognitive function, particularly in AD and schizophrenia

    Similar works

    Full text

    thumbnail-image

    Directory of Open Access Journals

    redirect
    oaioai:doaj.org/article:ad3ca81d3...
    Last time updated on 09/08/2016

    This paper was published in Directory of Open Access Journals.

    Having an issue?

    Is data on this page outdated, violates copyrights or anything else? Report the problem now and we will take corresponding actions after reviewing your request.